{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:17:07Z","timestamp":1790788627543,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009412","name":"School of Pharmacy, University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The detoxification of very long-chain and branched-chain fatty acids and the metabolism of cholesterol to form bile acids occur largely through a process called peroxisomal \u03b2-oxidation. Mutations in several peroxisomal proteins involved in \u03b2-oxidation have been reported, resulting in diseases characterized by neurological defects. The final step of the peroxisomal \u03b2-oxidation pathway is catalyzed by sterol carrier protein-x (SCPx), which is encoded by the\n                      <jats:italic>SCP2<\/jats:italic>\n                      gene. Previously, there have been two reports of SCPx deficiency, which resulted from a homozygous or compound heterozygous\n                      <jats:italic>SCP2<\/jats:italic>\n                      mutation. We report herein the first patient with a heterozygous\n                      <jats:italic>SCP2<\/jats:italic>\n                      mutation leading to SCPx deficiency.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical presentations of the patient included progressive brainstem neurodegeneration, cardiac dysrhythmia, muscle wasting, and azoospermia. Plasma fatty acid analysis revealed abnormal values of medium-, long-, and very long-chain fatty acids. Protein expression of SCPx and other enzymes involved in \u03b2-oxidation were altered between patient and normal fibroblasts. RNA sequencing and lipidomic analyses identified metabolic pathways that were altered between patient and normal fibroblasts including PPAR signaling, serotonergic signaling, steroid biosynthesis, and fatty acid degradation. Treatment with fenofibrate or 4-hydroxytamoxifen increased SCPx levels, and certain fatty acid levels in patient fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings suggest that the patient\u2019s\n                      <jats:italic>SCP2<\/jats:italic>\n                      mutation resulted in decreased protein levels of SCPx, which may be associated with many metabolic pathways. Increasing SCPx levels through pharmacological interventions may reverse some effects of SCPx deficiency. Collectively, this work provides insight into many of the clinical consequences of SCPx deficiency and provides evidence for potential treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40246-022-00408-w","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T09:05:42Z","timestamp":1661159142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects"],"prefix":"10.1186","volume":"16","author":[{"given":"Melanie","family":"Galano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-8568","authenticated-orcid":false,"given":"Vassilios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","volume":"21","author":"JK Reddy","year":"2001","unstructured":"Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Ann Rev Nutr. 2001;21:193\u2013230.","journal-title":"Ann Rev Nutr"},{"key":"408_CR2","first-page":"922","volume":"1863","author":"HR Waterham","year":"2016","unstructured":"Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. BBA-Mol Cell Res. 2016;1863:922\u201333.","journal-title":"BBA-Mol Cell Res"},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1086\/503921","volume":"78","author":"S Ferdinandusse","year":"2006","unstructured":"Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJA, Duran M, Marziniak M. Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet. 2006;78:1046\u201352.","journal-title":"Am J Hum Genet"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1212\/WNL.0000000000002157","volume":"85","author":"R Horvath","year":"2015","unstructured":"Horvath R, Lewis-Smith D, Douroudis K, Duff J, Keogh M, Pyle A, Fletcher N, Chinnery PF. SCP2 mutations and neurodegeneration with brain iron accumulation. Neurology. 2015;85:1909\u201311.","journal-title":"Neurology"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"e0149728","DOI":"10.1371\/journal.pone.0149728","volume":"11","author":"NC Li","year":"2016","unstructured":"Li NC, Fan JJ, Papadopoulos V. Sterol carrier protein-2, a nonspecific lipid-transfer protein, in intracellular cholesterol trafficking in testicular Leydig cells. PLoS ONE. 2016;11:e0149728.","journal-title":"PLoS ONE"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1021\/bi010217l","volume":"40","author":"AM Gallegos","year":"2001","unstructured":"Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Schroeder F. Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics. Biochemistry. 2001;40:6493\u2013506.","journal-title":"Biochemistry"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"18723","DOI":"10.1074\/jbc.270.32.18723","volume":"270","author":"L Puglielli","year":"1995","unstructured":"Puglielli L, Rigotti A, Greco AV, Santos MJ, Nervi F. Sterol carrier protein-2 is invovled in cholesterol transfer from the endoplasmic-reticulum to the plasma membrane in human fibrobalsts. J Biol Chem. 1995;270:18723\u20136.","journal-title":"J Biol Chem"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0005-2736(91)90170-D","volume":"1070","author":"TWJ Gadella","year":"1991","unstructured":"Gadella TWJ, Wirtz KWA. The low-affinity lipid-binding site of the nonspecific lipid transfer protein: implications for its mode of action. Biochem Biophys Acta. 1991;1070:237\u201345.","journal-title":"Biochem Biophys Acta"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1021\/bi00037a033","volume":"34","author":"F Schroeder","year":"1995","unstructured":"Schroeder F, Myerspayne SC, Billheimer JT, Wood WG. Probing the ligand-binding sites of fatty acid and sterol carrier proteins: effects of ethanol. Biochemistry. 1995;34:11919\u201327.","journal-title":"Biochemistry"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1021\/bi962317a","volume":"36","author":"NJ Stolowich","year":"1997","unstructured":"Stolowich NJ, Frolov A, Atshaves B, Murphy EJ, Jolly CA, Billheimer JT, Scott AI, Schroeder F. The sterol carrier protein-2 fatty acid binding site: An NMR, circular dichroic, and fluorescence spectroscopic determination. Biochemistry. 1997;36:1719\u201329.","journal-title":"Biochemistry"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11745-997-0154-5","volume":"32","author":"A Frolov","year":"1997","unstructured":"Frolov A, Miller K, Billheimer JT, Cho TH, Schroeder F. Lipid specificity and location of the sterol carrier protein-2 fatty acid-binding site: A fluorescence displacement and energy transfer study. Lipids. 1997;32:1201\u20139.","journal-title":"Lipids"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0163-7827(01)00015-7","volume":"40","author":"AM Gallegos","year":"2001","unstructured":"Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh AL, Martin GG, Chao H, Kier AB, Schroeder F. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res. 2001;40:498\u2013563.","journal-title":"Prog Lipid Res"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1101\/gad.12.8.1189","volume":"12","author":"U Seedorf","year":"1998","unstructured":"Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KWA, Wanders RJA, et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2 sterol carrier protein-x gene function. Genes Dev. 1998;12:1189\u2013201.","journal-title":"Genes Dev"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"31878","DOI":"10.1074\/jbc.271.50.31878","volume":"271","author":"A Frolov","year":"1996","unstructured":"Frolov A, Cho TH, Billheimer JT, Schroeder F. Sterol carrier protein-2, a new fatty acyl coenzyme a-binding protein. J Biol Chem. 1996;271:31878\u201384.","journal-title":"J Biol Chem"},{"key":"408_CR15","first-page":"700","volume":"1771","author":"F Schroeder","year":"2007","unstructured":"Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, Jefferson JR, Ball JM, Kier AB. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. BBA-Mol Cell Biol L. 2007;1771:700\u201318.","journal-title":"BBA-Mol Cell Biol L"},{"key":"408_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1083\/jcb.108.4.1353","volume":"108","author":"GA Keller","year":"1989","unstructured":"Keller GA, Scallen TJ, Clarke D, Maher PA, Krisans SK, Singer SJ. Subcellular-localizations of steroi carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. J Cell Biol. 1989;108:1353\u201361.","journal-title":"J Cell Biol"},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fphys.2013.00145","volume":"4","author":"M Nordgren","year":"2013","unstructured":"Nordgren M, Wang B, Apanasets O, Fransen M. Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectives. Front Physiol. 2013;4:145.","journal-title":"Front Physiol"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, De Bosscher K. Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation. Endocr Rev. 2018;39:760\u2013802.","journal-title":"Endocr Rev"},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1074\/jbc.274.5.2766","volume":"274","author":"P Ellinghaus","year":"1999","unstructured":"Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-\/ sterol carrier protein x-deficient mice. J Biol Chem. 1999;274:2766\u201372.","journal-title":"J Biol Chem"},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JY Chiang","year":"2009","unstructured":"Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955\u201366.","journal-title":"J Lipid Res"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4318\/tjg.2013.0528","volume":"24","author":"C Yunfeng","year":"2013","unstructured":"Yunfeng C, Zhonglian L, Erpeng Z, Ju Z, Naiqiang C. Increased bile lithogenicity by SCP2 via HMGCR and CYP7A1 regulation in human hepatocytes. Turk J Gastroenterol. 2013;24:241\u201350.","journal-title":"Turk J Gastroenterol"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbalip.2007.02.012","volume":"1771","author":"WL Miller","year":"2007","unstructured":"Miller WL. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim Biophys Acta. 2007;1771:663\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fneur.2020.00437","volume":"11","author":"AV Alessenko","year":"2020","unstructured":"Alessenko AV, Albi E. Exploring sphingolipid implications in neurodegeneration. Front Neurol. 2020;11:437.","journal-title":"Front Neurol"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.12997\/jla.2020.9.3.380","volume":"9","author":"M Taniguchi","year":"2020","unstructured":"Taniguchi M, Okazaki T. Ceramide\/sphingomyelin rheostat regulated by sphingomyelin synthases and chronic diseases in murine models. J Lipid Atheroscler. 2020;9:380\u2013405.","journal-title":"J Lipid Atheroscler"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1586\/14779072.6.10.1319","volume":"6","author":"RS Rosenson","year":"2008","unstructured":"Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther. 2008;6:1319\u201330.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1194\/jlr.M300111-JLR200","volume":"45","author":"TB Dansen","year":"2004","unstructured":"Dansen TB, Kops GJ, Denis S, Jelluma N, Wanders RJ, Bos JL, Burgering BM, Wirtz KW. Regulation of sterol carrier protein gene expression by the forkhead transcription factor FOXO3a. J Lipid Res. 2004;45:81\u20138.","journal-title":"J Lipid Res"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jbmr.3995","volume":"35","author":"A Howaldt","year":"2020","unstructured":"Howaldt A, Hennig AF, Rolvien T, R\u00f6ssler U, Stelzer N, Knaus A, B\u00f6ttger S, Zustin J, Gei\u00dfler S, Oheim R, et al. Adult osteosclerotic metaphyseal dysplasia with progressive osteonecrosis of the jaws and abnormal bone resorption pattern due to a LRRK1 splice site mutation. J Bone Miner Res. 2020;35:1322\u201332.","journal-title":"J Bone Miner Res"},{"key":"408_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF02012448","volume":"23","author":"G Nishimura","year":"1993","unstructured":"Nishimura G, Kozlowski K. Osteosclerotic metaphyseal dysplasia. Pediatr Radiol. 1993;23:450\u20132.","journal-title":"Pediatr Radiol"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10048-013-0383-8","volume":"15","author":"EC Schulte","year":"2014","unstructured":"Schulte EC, Ellwanger DC, Dihanich S, Manzoni C, Stangl K, Schormair B, Graf E, Eck S, Mollenhauer B, Haubenberger D, et al. Rare variants in LRRK1 and Parkinson\u2019s disease. Neurogenetics. 2014;15:49\u201357.","journal-title":"Neurogenetics"},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"a003954","DOI":"10.1101\/mcs.a003954","volume":"5","author":"M Blomqvist","year":"2019","unstructured":"Blomqvist M, Smeland MF, Lindgren J, Sikora P, Riise Stensland HMF, Asin-Cayuela J. \u03b2-Mannosidosis caused by a novel homozygous intragenic inverted duplication in. Cold Spring Harb Mol Case Stud. 2019;5:a003954.","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13023-020-01508-3","volume":"15","author":"D Safka Brozkova","year":"2020","unstructured":"Safka Brozkova D, Varga L, Uhrova Meszarosova A, Slobodova Z, Skopkova M, Soltysova A, Ficek A, Jencik J, Lastuvkova J, Gasperikova D, Seeman P. Variant c.2158\u20132A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant. Orphanet J Rare Dis. 2020;15:222.","journal-title":"Orphanet J Rare Dis"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJM199904153401507","volume":"340","author":"SJ Scheinman","year":"1999","unstructured":"Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG. Genetic disorders of renal electrolyte transport. N Engl J Med. 1999;340:1177\u201387.","journal-title":"N Engl J Med"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1523-1755.1998.00718.x","volume":"53","author":"SJ Scheinman","year":"1998","unstructured":"Scheinman SJ. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int. 1998;53:3\u201317.","journal-title":"Kidney Int"},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/379445a0","volume":"379","author":"SE Lloyd","year":"1996","unstructured":"Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, et al. A common molecular basis for three inherited kidney stone diseases. Nature. 1996;379:445\u20139.","journal-title":"Nature"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jmg.32.1.44","volume":"32","author":"RH Boerman","year":"1995","unstructured":"Boerman RH, Ophoff RA, Links TP, van Eijk R, Sandkuijl LA, Elbaz A, Vale-Santos JE, Wintzen AR, van Deutekom JC, Isles DE. Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis. J Med Genet. 1995;32:44\u20137.","journal-title":"J Med Genet"},{"key":"408_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/archneur.1985.04060010034012","volume":"42","author":"OJ Buruma","year":"1985","unstructured":"Buruma OJ, Bots GT, Went LN. Familial hypokalemic periodic paralysis: 50-year follow-up of a large family. Arch Neurol. 1985;42:28\u201331.","journal-title":"Arch Neurol"},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/01.WNL.0000143383.91137.00","volume":"63","author":"TM Miller","year":"2004","unstructured":"Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, McManis P, Griggs RC, Angelini C, Servidei S, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004;63:1647\u201355.","journal-title":"Neurology"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"G939","DOI":"10.1152\/ajpgi.00308.2006","volume":"292","author":"BP Atshaves","year":"2007","unstructured":"Atshaves BP, McIntosh AL, Landrock D, Payne HR, Mackie JT, Maeda N, Ball J, Schroeder F, Kier AB. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism. Am J Physiol Gastrointest Liver Physiol. 2007;292:G939-951.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1006\/bbrc.1997.7007","volume":"236","author":"RJ Wanders","year":"1997","unstructured":"Wanders RJ, Denis S, Wouters F, Wirtz KW, Seedorf U. Sterol carrier protein X (SCPx) is a peroxisomal branched-chain beta-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: a new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes. Biochem Biophys Res Commun. 1997;236:565\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1194\/jlr.M075457","volume":"58","author":"SM Storey","year":"2017","unstructured":"Storey SM, Huang H, McIntosh AL, Martin GG, Kier AB, Schroeder F. Impact of. J Lipid Res. 2017;58:1153\u201365.","journal-title":"J Lipid Res"},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0022-2275(20)32150-7","volume":"40","author":"C Wolfrum","year":"1999","unstructured":"Wolfrum C, Ellinghaus P, Fobker M, Seedorf U, Assmann G, B\u00f6rchers T, Spener F. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res. 1999;40:708\u201314.","journal-title":"J Lipid Res"},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1073\/pnas.96.14.7871","volume":"96","author":"LX Shen","year":"1999","unstructured":"Shen LX, Basilion JP, Stanton VP. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A. 1999;96:7871\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/CIRCGEN.119.002853","volume":"13","author":"K Kato","year":"2020","unstructured":"Kato K, Ohno S, Sonoda K, Fukuyama M, Makiyama T, Ozawa T, Horie M. Missense mutation causes nonsense-mediated mRNA decay and severe dilated cardiomyopathy. Circ Genom Precis Med. 2020;13:435\u201343.","journal-title":"Circ Genom Precis Med"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/brv.12527","volume":"94","author":"AF Johnson","year":"2019","unstructured":"Johnson AF, Nguyen HT, Veitia RA. Causes and effects of haploinsufficiency. Biol Rev Camb Philos Soc. 2019;94:1774\u201385.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.3390\/ijms22168969","volume":"22","author":"M Tahri-Joutey","year":"2021","unstructured":"Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N. Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPAR\u03b1. Int J Mol Sci. 2021;22:8969.","journal-title":"Int J Mol Sci"},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"G1333","DOI":"10.1152\/ajpgi.2001.281.6.G1333","volume":"281","author":"JK Reddy","year":"2001","unstructured":"Reddy JK. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1333-1339.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"408_CR47","first-page":"83","volume":"3","author":"RJ Wanders","year":"2015","unstructured":"Wanders RJ, Waterham HR, Ferdinandusse S. Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front Cell Dev Biol. 2015;3:83.","journal-title":"Front Cell Dev Biol"},{"key":"408_CR48","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2015;62:720\u201333.","journal-title":"J Hepatol"},{"key":"408_CR49","first-page":"351","volume":"20","author":"M Kohjima","year":"2007","unstructured":"Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med. 2007;20:351\u20138.","journal-title":"Int J Mol Med"},{"key":"408_CR50","first-page":"F777","volume":"275","author":"F Ouali","year":"1998","unstructured":"Ouali F, Djouadi F, Merlet-B\u00e9nichou C, Bastin J. Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney. Am J Physiol. 1998;275:F777-784.","journal-title":"Am J Physiol"},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/0-306-46818-2_30","volume":"466","author":"N Latruffe","year":"1999","unstructured":"Latruffe N, Nicolas-Frances V, Dasari VK, Osumi T. Studies on regulation of the peroxisomal beta-oxidation at the 3-ketothiolase step: dissection of the rat liver thiolase B gene promoter. Adv Exp Med Biol. 1999;466:253\u20139.","journal-title":"Adv Exp Med Biol"},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbalip.2017.12.013","volume":"1863","author":"S Milligan","year":"2018","unstructured":"Milligan S, Martin GG, Landrock D, McIntosh AL, Mackie JT, Schroeder F, Kier AB. Ablating both Fabp1 and Scp2\/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863:323\u201338.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"408_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/me.2006-0534","volume":"22","author":"SM Eacker","year":"2008","unstructured":"Eacker SM, Agrawal N, Qian K, Dichek HL, Gong EY, Lee K, Braun RE. Hormonal regulation of testicular steroid and cholesterol homeostasis. Mol Endocrinol. 2008;22:623\u201335.","journal-title":"Mol Endocrinol"},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2014.02.012","volume":"30","author":"LB Smith","year":"2014","unstructured":"Smith LB, Walker WH. The regulation of spermatogenesis by androgens. Semin Cell Dev Biol. 2014;30:2\u201313.","journal-title":"Semin Cell Dev Biol"},{"key":"408_CR55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4161\/spmg.1.2.16956","volume":"1","author":"WH Walker","year":"2011","unstructured":"Walker WH. Testosterone signaling and the regulation of spermatogenesis. Spermatogenesis. 2011;1:116\u201320.","journal-title":"Spermatogenesis"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tins.2010.05.005","volume":"33","author":"EA Daubert","year":"2010","unstructured":"Daubert EA, Condron BG. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010;33:424\u201334.","journal-title":"Trends Neurosci"},{"key":"408_CR57","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/acschemneuro.5b00135","volume":"6","author":"S Claeysen","year":"2015","unstructured":"Claeysen S, Bockaert J, Giannoni P. Serotonin: a new hope in Alzheimer\u2019s disease? ACS Chem Neurosci. 2015;6:940\u20133.","journal-title":"ACS Chem Neurosci"},{"key":"408_CR58","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, Hayreh D, D\u2019Angelo G, Benzinger T, Yoon H, et al. Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A. 2011;108:14968\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"408_CR59","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10545-013-9611-5","volume":"36","author":"SE Olpin","year":"2013","unstructured":"Olpin SE. Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability. J Inherit Metab Dis. 2013;36:645\u201358.","journal-title":"J Inherit Metab Dis"},{"key":"408_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1440-1681.2006.04342.x","volume":"33","author":"RH Ritchie","year":"2006","unstructured":"Ritchie RH, Delbridge LM. Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clin Exp Pharmacol Physiol. 2006;33:159\u201366.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"408_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2009.08.053","volume":"1296","author":"PF Schuck","year":"2009","unstructured":"Schuck PF, Ferreira GAC, Tonin AM, Viegas CM, Busanello EN, Moura AP, Zanatta A, Klamt F, Wajner M. Evidence that the major metabolites accumulating in medium-chain acyl-CoA dehydrogenase deficiency disturb mitochondrial energy homeostasis in rat brain. Brain Res. 2009;1296:117\u201326.","journal-title":"Brain Res"},{"key":"408_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lfs.2010.05.019","volume":"87","author":"PF Schuck","year":"2010","unstructured":"Schuck PF, Ferreira GAC, Tahara EB, Klamt F, Kowaltowski AJ, Wajner M. cis-4-decenoic acid provokes mitochondrial bioenergetic dysfunction in rat brain. Life Sci. 2010;87:139\u201346.","journal-title":"Life Sci"},{"key":"408_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11010-011-1119-4","volume":"361","author":"G Scaini","year":"2012","unstructured":"Scaini G, Simon KR, Tonin AM, Busanello EN, Moura AP, Ferreira GC, Wajner M, Streck EL, Schuck PF. Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle. Mol Cell Biochem. 2012;361:329\u201335.","journal-title":"Mol Cell Biochem"},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0161-6420(98)95019-9","volume":"105","author":"T Tyni","year":"1998","unstructured":"Tyni T, Kivel\u00e4 T, Lappi M, Summanen P, Nikoskelainen E, Pihko H. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology. 1998;105:810\u201324.","journal-title":"Ophthalmology"},{"key":"408_CR65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1023\/A:1022874103630","volume":"28","author":"G Leipnitz","year":"2003","unstructured":"Leipnitz G, Schuck PF, Ribeiro CA, Dalcin KB, Assis DR, Barschak AG, Pulrolnik V, Wannmacher CM, Wyse AT, Wajner M. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. Neurochem Res. 2003;28:771\u20137.","journal-title":"Neurochem Res"},{"key":"408_CR66","doi-asserted-by":"publisher","first-page":"H2124","DOI":"10.1152\/ajpheart.2000.279.5.H2124","volume":"279","author":"GC Sparagna","year":"2000","unstructured":"Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol. 2000;279:H2124-2132.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3727\/000000006780666948","volume":"13","author":"J Sarkar","year":"2007","unstructured":"Sarkar J, Qi C, Guo D, Ahmed MR, Jia Y, Usuda N, Viswakarma N, Rao MS, Reddy JK. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver. Gene Expr. 2007;13:255\u201369.","journal-title":"Gene Expr"},{"key":"408_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/250126","author":"N Viswakarma","year":"2010","unstructured":"Viswakarma N, Jia Y, Bai L, Vluggens A, Borensztajn J, Xu J, Reddy JK. Coactivators in PPAR-regulated gene expression. PPAR Res. 2010. https:\/\/doi.org\/10.1155\/2010\/250126.","journal-title":"PPAR Res"},{"key":"408_CR69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/mnfr.201100798","volume":"56","author":"Y Jia","year":"2012","unstructured":"Jia Y, Kim JY, Jun HJ, Kim SJ, Lee JH, Hoang MH, Hwang KY, Um SJ, Chang HI, Lee SJ. The natural carotenoid astaxanthin, a PPAR-\u03b1 agonist and PPAR-\u03b3 antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. Mol Nutr Food Res. 2012;56:878\u201388.","journal-title":"Mol Nutr Food Res"},{"key":"408_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jmedgenet-2020-106936","volume":"58","author":"S Shickh","year":"2021","unstructured":"Shickh S, Gutierrez Salazar M, Zakoor KR, L\u00e1zaro C, Gu J, Goltz J, Kleinman D, Noor A, Khalouei S, Mighton C, et al. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study. J Med Genet. 2021;58:275\u201383.","journal-title":"J Med Genet"},{"key":"408_CR71","first-page":"22","volume":"2021","author":"M Galano","year":"2021","unstructured":"Galano M, Li Y, Li L, Sottas C, Papadopoulos V. Role of constitutive STAR in leydig cells. Int J Mol Sci. 2021;2021:22.","journal-title":"Int J Mol Sci"},{"key":"408_CR72","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, Bandyopadhyay S, Jones KN, Kelly S, Shaner RL, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51:3299\u2013305.","journal-title":"J Lipid Res"},{"key":"408_CR73","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.bbalip.2011.07.006","volume":"1811","author":"O Quehenberger","year":"2011","unstructured":"Quehenberger O, Armando AM, Dennis EA. High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry. Biochim Biophys Acta. 2011;1811:648\u201356.","journal-title":"Biochim Biophys Acta"},{"key":"408_CR74","doi-asserted-by":"publisher","first-page":"27688","DOI":"10.1038\/srep27688","volume":"6","author":"L L\u00f6fgren","year":"2016","unstructured":"L\u00f6fgren L, Forsberg GB, St\u00e5hlman M. The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue. Sci Rep. 2016;6:27688.","journal-title":"Sci Rep"},{"key":"408_CR75","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1194\/jlr.D051581","volume":"55","author":"PR Baker","year":"2014","unstructured":"Baker PR, Armando AM, Campbell JL, Quehenberger O, Dennis EA. Three-dimensional enhanced lipidomics analysis combining UPLC, differential ion mobility spectrometry, and mass spectrometric separation strategies. J Lipid Res. 2014;55:2432\u201342.","journal-title":"J Lipid Res"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-022-00408-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T09:05:53Z","timestamp":1661159153000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-022-00408-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s40246-022-00408-w","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This individual was enrolled in the Adults with Undiagnosed Rare Disease genome sequencing research study approved by the Mount Sinai Hospital Research Ethics Board (#12\u20130222-E) [\n                      \n                      ]. These studies abide by the Declaration of Helsinki principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}